Titulo:

Therapeutic efficacy of Chymotrypsin in acute bovine mastitis
.

Guardado en:

0122-0268

1909-0544

21

2016-05-02

5416

5425

info:eu-repo/semantics/openAccess

http://purl.org/coar/access_right/c_abf2

id oai:revistas.unicordoba.edu.co:article_607
record_format ojs
spelling Therapeutic efficacy of Chymotrypsin in acute bovine mastitis
Leal G, Marco
Fármaco
producción
terapia
21
2
Núm. 2 , Año 2016 : Revista MVZ Córdoba Volumen 21(2) Mayo-Agosto 2016
Artículo de revista
Journal article
2016-05-02T00:00:00Z
2016-05-02T00:00:00Z
2016-05-02
application/pdf
text/html
Universidad de Córdoba
Revista MVZ Córdoba
0122-0268
1909-0544
https://revistamvz.unicordoba.edu.co/article/view/607
10.21897/rmvz.607
https://doi.org/10.21897/rmvz.607
https://creativecommons.org/licenses/by-nc-sa/4.0/
5416
5425
Petrovski KR, Trajcev M, Buneski G.A. Review of the factors affectingthe costs of bovine mastitis. J S Afr Vet Assoc 2006; 77(2):52-60. http://dx.doi.org/10.4102/jsava.v77i2.344
Ericsson UH, Lindberg A, Persson WK, Ekman T, Artursson K, Nilsson OM et al. Microbial etiology of acute clinical mastitis and agent-specific risk factors. Vet Microbiology 2009; 137(1-2):90-7. http://dx.doi.org/10.1016/j.vetmic.2008.12.005
Hogeveen H, Kamphuis C, Steeneveld W, Mollenhorst H. Sensors and clinical mastitis--the quest for the perfect alert. Sensors (Basel, Switzerland) 2010; 10(9):7991-8009. http://dx.doi.org/10.3390/s100907991
Kim Y, Atalla H, Mallard B, Robert C, Karrow N. Changes in Holstein cow milk and serum proteins during intramammary infection with three different strains of Staphylococcus aureus. BMC Vet Res 2011; 7(1):51. http://dx.doi.org/10.1186/1746-6148-7-51
Nagahata H, Kawai H, Higuchi H, Kawai K, Yayou K, Chang CJ. Altered leukocyte responsiveness in dairy cows with naturally occurring chronic Staphylococcus aureus mastitis. J Vet Med Sci 2011; 73(7):885-94. http://dx.doi.org/10.1292/jvms.10-0379
Zhao X, Lacasse P. Mammary tissue damage during bovine mastitis: causes and control. J Anim Sci 2008; 86(13):57-65. http://dx.doi.org/10.2527/jas.2007-0302
Barkema HW, Schukken YH, Zadoks RN. Invited Review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci 2006; 89(6): 1877-95. http://dx.doi.org/10.3168/jds.S0022-0302(06)72256-1
McDougall S, Bryan M, Tiddy RM. Effect of treatment with the nonsteroidal antiinflammatory meloxicam on milk production, somatic cell count, probability of re-treatment, and culling of dairy cows with mild clinical mastitis. J Dairy Sci 2009; 92(9):4421-31. http://dx.doi.org/10.3168/jds.2009-2284
Rantala M, Kaartinen L, Välim&aki E, Stryrman M, Hiekkaranta M, et al. Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. J vet Pharmacol Therap 2002; 25(4):251-8 http://dx.doi.org/10.1046/j.1365-2885.2002.00411.x
Banting A, Banting S, Heinonen K, Mustonen K. Efficacy of oral and arenteral ketoprofen in lactating cows with endotoxin-induced acute mastitis. Vet Rec 2008; 163:506-509 http://dx.doi.org/10.1136/vr.163.17.506
Fajt V, Wagner S, Norby B. Analgesic drug administration and attitudes about analgesia in cattle among bovine practitioners in the United States. J Am Vet Med Assoc 2011; 238(6):755-767. http://dx.doi.org/10.2460/javma.238.6.755
Ziv G, Shem-Tov M, Ascher F. Combined effect of ampicillin, colistin and dexamethasone administered intramuscularly to dairy cows on the clinico-pathological course of E. coli-endotoxin mastitis. Vet Res 1998; 29(1):89-98.
Kania B, Kania K. Pharmacological and toxicological aspects of combination of beta-lactam and aminoglycoside antibiotic, prednisolone and procaine hydrochloride on the example of Vetramycin. Pol J Vet Sci 2003; 6(4):279-296.
Kruger M. Untersuchungen zum einfluss der proteolytischen enzyme trypsin, chymotrypsin und papain auf euterpathogene mikroorganismen. Tierarztl Prax 1999; 27:207-215.
Drillich M, Raab D, Wittke M, Heuwieser W. Treatment of chronic endometritis in dairy cows with an intrauterine application of enzymes. A field trial. Theriogenology 2005; 63(7):1811-23. http://dx.doi.org/10.1016/j.theriogenology.2004.05.031
Kwiecinski J, Josefsson E, Jin T. Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease. Inflamm Res 2011; 60(11):1021-9. http://dx.doi.org/10.1007/s00011-011-0363-0
Szaba F, Smiley S. Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 2002; 99:1053-1059. http://dx.doi.org/10.1182/blood.V99.3.1053
Chuaqui, B., González, S. Manual de Patología General. segunda edicián. Universidad Catálica de Chile: Santiago de Chile; 1999
Levi M, Keller T, Gorp VE, Cate TH. Infection and inflammation and the coagulation system. Cardiovascular research 2003; 60:26-39. http://dx.doi.org/10.1016/S0008-6363(02)00857-X
Levi M, van der Poll T. Inflammation and coagulation. Critical care medicine 2010; 38(2):S26-34. http://dx.doi.org/10.1097/CCM.0b013e3181c98d21
Biemond B, Levi M, Cate TH. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: Effect of interventions in the cytokine and coagulation cascades. Clin Sci 1995; 88:587-594. http://dx.doi.org/10.1042/cs0880587
Van der Poll T, Levi M, Buller H. Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991; 174:729-732. http://dx.doi.org/10.1084/jem.174.3.729
Sazonova IY, Thomas BM, Gladysheva IP, Houng K, Reed GL. Fibrinolysis is amplified by converting alpha-antiplasmin from a plasmin inhibitor to a substrate. J Thromb Haemost. 2007; 5(10):2087-94. http://dx.doi.org/10.1111/j.1538-7836.2007.02652.x
Kwiecinski J, Josefsson E, Mitchell J, Higgins J, Magnusson M, Foster T, et al. Activation of plasminogen by staphylokinase reduces the severity of Staphylococcus aureus systemic infection. J Infect Dis. 2010; 202(7):1041-9. http://dx.doi.org/10.1086/656140
Jin T, Bokarewa M, McIntyre L. Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J Med Microbiol 2003; 52:919-39. http://dx.doi.org/10.1099/jmm.0.05145-0
Guo Y, Li J, Hagström E, Ny T. Beneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice. PloS one 2011; 6(9):e24774. http://dx.doi.org/10.1371/journal.pone.0024774
Kivaria FM, Noordhuizen JP, Nielen M. (2007). Interpretation of California mastitis test scores using Staphylococcus aureus culture results for screening of subclinical mastitis in low yielding smallholder dairy cows in the Dar es Salaam region of Tanzania. Prev Vet Med, 2007; 78(3-4):274-85. http://dx.doi.org/10.1016/j.prevetmed.2006.10.011
Oliver, S. Antimicrobial resistance of Mastitis pathogens. Vet Clin Food Anim 28 (2012) 165−185. http://dx.doi.org/10.1016/j.cvfa.2012.03.005
García, B. Pedro. Inflamacián. Rev.R.Acad.Cienc.Exact.Fís.Nat. (Esp) Vol. 102, N°. 1, pp 91-159, 2008 IX Programa de Promocián de la Cultura Científica y Tecnolágica.
https://revistamvz.unicordoba.edu.co/article/download/607/720
https://revistamvz.unicordoba.edu.co/article/download/607/721
info:eu-repo/semantics/article
http://purl.org/coar/resource_type/c_6501
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/version/c_970fb48d4fbd8a85
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
Text
Publication
institution UNIVERSIDAD DE CORDOBA
thumbnail https://nuevo.metarevistas.org/UNIVERSIDADDECORDOBA/logo.png
country_str Colombia
collection Revista MVZ Córdoba
title Therapeutic efficacy of Chymotrypsin in acute bovine mastitis
spellingShingle Therapeutic efficacy of Chymotrypsin in acute bovine mastitis
Leal G, Marco
Fármaco
producción
terapia
title_short Therapeutic efficacy of Chymotrypsin in acute bovine mastitis
title_full Therapeutic efficacy of Chymotrypsin in acute bovine mastitis
title_fullStr Therapeutic efficacy of Chymotrypsin in acute bovine mastitis
title_full_unstemmed Therapeutic efficacy of Chymotrypsin in acute bovine mastitis
title_sort therapeutic efficacy of chymotrypsin in acute bovine mastitis
author Leal G, Marco
author_facet Leal G, Marco
topic Fármaco
producción
terapia
topic_facet Fármaco
producción
terapia
citationvolume 21
citationissue 2
citationedition Núm. 2 , Año 2016 : Revista MVZ Córdoba Volumen 21(2) Mayo-Agosto 2016
publisher Universidad de Córdoba
ispartofjournal Revista MVZ Córdoba
source https://revistamvz.unicordoba.edu.co/article/view/607
language
format Article
rights https://creativecommons.org/licenses/by-nc-sa/4.0/
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
type_driver info:eu-repo/semantics/article
type_coar http://purl.org/coar/resource_type/c_6501
type_version info:eu-repo/semantics/publishedVersion
type_coarversion http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content Text
publishDate 2016-05-02
date_accessioned 2016-05-02T00:00:00Z
date_available 2016-05-02T00:00:00Z
url https://revistamvz.unicordoba.edu.co/article/view/607
url_doi https://doi.org/10.21897/rmvz.607
issn 0122-0268
eissn 1909-0544
doi 10.21897/rmvz.607
citationstartpage 5416
citationendpage 5425
url2_str_mv https://revistamvz.unicordoba.edu.co/article/download/607/720
url3_str_mv https://revistamvz.unicordoba.edu.co/article/download/607/721
_version_ 1811201106202591232